Is 5P8 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 5P8 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 5P8's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 5P8's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 5P8?
Key metric: As 5P8 is an unprofitable bank we use its Price-To-Book Ratio for relative valuation analysis.
The above table shows the Price to Book ratio for 5P8. This is calculated by dividing 5P8's market cap by their current
book value.
What is 5P8's PB Ratio?
PB Ratio
0.7x
Book
US$339.30m
Market Cap
US$234.70m
5P8 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Book vs Industry: 5P8 is good value based on its Price-To-Book Ratio (0.7x) compared to the European Banks industry average (0.8x).
Price to Book Ratio vs Fair Ratio
What is 5P8's PB Ratio
compared to its
Fair PB Ratio?
This is the expected PB Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
5P8 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio
0.7x
Fair PB Ratio
n/a
Price-To-Book vs Fair Ratio: Insufficient data to calculate 5P8's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst 5P8 forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
€10.50
€9.77
-6.9%
6.0%
€10.36
€9.18
n/a
2
Nov ’25
€9.05
€10.08
+11.4%
10.3%
€11.13
€9.04
n/a
2
Oct ’25
€9.10
€9.82
+8.0%
10.3%
€10.84
€8.81
n/a
2
Sep ’25
€9.75
€9.82
+0.7%
12.9%
€11.09
€8.55
n/a
2
Aug ’25
€10.30
€9.82
-4.7%
12.9%
€11.09
€8.55
n/a
2
Jul ’25
€8.30
€8.15
-1.8%
8.6%
€8.85
€7.45
n/a
2
Jun ’25
€8.25
€8.41
+1.9%
11.1%
€9.34
€7.48
n/a
2
May ’25
€7.95
€8.41
+5.8%
11.1%
€9.34
€7.48
n/a
2
Apr ’25
€8.50
€8.76
+3.1%
5.3%
€9.23
€8.30
n/a
2
Mar ’25
€8.55
€9.22
+7.8%
10.0%
€10.14
€8.30
n/a
2
Feb ’25
€8.65
€9.23
+6.7%
10.0%
€10.15
€8.30
n/a
2
Jan ’25
€8.80
€8.24
-6.3%
12.7%
€9.29
€7.20
n/a
2
Dec ’24
€7.85
€7.65
-2.5%
4.6%
€8.01
€7.30
n/a
2
Nov ’24
€7.05
€7.65
+8.6%
4.6%
€8.01
€7.30
€9.05
2
Oct ’24
€7.80
€8.73
+12.0%
2.7%
€8.97
€8.50
€9.10
2
Sep ’24
€8.40
€9.20
+9.5%
10.0%
€10.12
€8.28
€9.75
2
Aug ’24
€9.10
€9.11
+0.05%
10.0%
€10.02
€8.19
€10.30
2
Jul ’24
€9.30
€9.24
-0.7%
9.2%
€10.09
€8.39
€8.30
2
Jun ’24
€8.60
€8.60
+0.03%
1.9%
€8.76
€8.44
€8.25
2
Apr ’24
€8.75
€11.71
+33.8%
2.0%
€11.94
€11.48
€8.50
2
Mar ’24
€11.30
€11.71
+3.6%
2.0%
€11.94
€11.48
€8.55
2
Feb ’24
€10.80
€11.71
+8.4%
2.0%
€11.94
€11.48
€8.65
2
Jan ’24
€11.90
€13.55
+13.9%
3.7%
€14.05
€13.05
€8.80
2
Dec ’23
€12.40
€13.55
+9.3%
3.7%
€14.05
€13.05
€7.85
2
Nov ’23
€12.16
€13.55
+11.4%
3.7%
€14.05
€13.05
€7.05
2
Analyst Forecast: Target price is lower than the current share price.